Lv1
38 积分 2024-09-01 加入
Individualized Rituximab Treatment for Neuromyelitis Optica Spectrum Disorders
1个月前
已完结
A real-world study on the utility of regular rituximab treatment for neuromyelitis optica spectrum disorder
2个月前
已完结
川崎病诊断和急性期治疗专家共识
2个月前
已完结
Efficacy and Safety of Rituximab Therapy in Neuromyelitis Optica Spectrum Disorders
3个月前
已完结
The spectrum of neuromyelitis optica
3个月前
已完结
Rituximab Pharmacokinetics in Patients With Rheumatoid Arthritis: B-Cell Levels Do Not Correlate With Clinical Response
7个月前
已完结
Efficacy and safety of repeated low-dose rituximab therapy in relapsing-remitting multiple sclerosis: A retrospective case series study
7个月前
已完结
Neuromyelitis optica spectrum disorders: long-term safety and efficacy of rituximab in Caucasian patients
7个月前
已完结
Rituximab, an Anti-CD20 Monoclonal Antibody: History and Mechanism of Action
7个月前
已完结
皖公网安备34019202002308
